Literature DB >> 18675694

Time course of morphologic effects on different retinal compartments after ranibizumab therapy in age-related macular degeneration.

Christian Ahlers1, Isabelle Golbaz, Geraldine Stock, Alexander Fous, Sheila Kolar, Christian Pruente, Ursula Schmidt-Erfurth.   

Abstract

PURPOSE: To analyze the effect of ranibizumab therapy on retinal and subretinal compartments in age-related macular degeneration and to compare the time course of compartment specific effects to visual function.
DESIGN: Prospective noncomparative case series. PARTICIPANTS: Fourteen patients with changes in 3 major compartments owing to neovascular age-related macular degeneration.
METHODS: Standard treatment with 3 monthly doses of intravitreal ranibizumab was performed. Eyes were examined at baseline and weeks 1, 4, and 12 using a standardized protocol. Manual segmentation was applied to all 128 B-scans contained in a macular raster scan (MRS). MAIN OUTCOME MEASURES: Morphology and time course of different retinal and subretinal compartments.
RESULTS: High-definition optical coherence tomography and manual segmentation allowed for precise identification of volumes within individual compartments. All morphologic parameters responded positively to therapy, but demonstrated a specific time course. Subretinal fluid was identified as the most relevant factor for visual function, whereas changes in retinal and subpigment epithelial volumes did not correlate with the time course of functional rehabilitation.
CONCLUSION: Analysis of MRS identified a characteristic impact of therapy on retinal and subretinal morphology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18675694     DOI: 10.1016/j.ophtha.2008.05.017

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  15 in total

1.  [Specific alterations in the retinal microstructure in neovascular age-related macular degeneration under anti-VEGF therapy. A detailed analysis of intraretinal changes and their possible role for follow-up].

Authors:  T Schneiderbauer; C Ahlers; G Stock; I Golbaz; C Schütze; S Sacu; U Schmidt-Erfurth
Journal:  Ophthalmologe       Date:  2011-01       Impact factor: 1.059

2.  [Influence of antiangiogenetic therapy on retinal thickness values in age-related macular degeneration].

Authors:  I Golbaz; C Ahlers; C Schütze; G Stock; G Mylonas; C Prünte; U Schmidt-Erfurth
Journal:  Ophthalmologe       Date:  2009-12       Impact factor: 1.059

3.  Imaging of the retinal pigment epithelium in age-related macular degeneration using polarization-sensitive optical coherence tomography.

Authors:  Christian Ahlers; Erich Götzinger; Michael Pircher; Isabelle Golbaz; Franz Prager; Christopher Schütze; Bernhard Baumann; Christoph K Hitzenberger; Ursula Schmidt-Erfurth
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-09-24       Impact factor: 4.799

4.  Effects of retinal morphology on contrast sensitivity and reading ability in neovascular age-related macular degeneration.

Authors:  Pearse A Keane; Praveen J Patel; Yanling Ouyang; Fred K Chen; Felicia Ikeji; Alexander C Walsh; Adnan Tufail; Srinivas R Sadda
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-16       Impact factor: 4.799

5.  [Neovascular age-related macular degeneration under anti-angiogenic therapy : Subretinal fluid is a relevant prognostic parameter].

Authors:  E Einwallner; C Ahlers; I Golbaz; C Schütze; R Dunavölgyi; G Stock; U M Schmidt-Erfurth
Journal:  Ophthalmologe       Date:  2010-02       Impact factor: 1.059

6.  Predicting visual outcomes for macular disease using optical coherence tomography.

Authors:  Pearse A Keane; Srinivas R Sadda
Journal:  Saudi J Ophthalmol       Date:  2011-01-26

7.  Targeted intraceptor nanoparticle therapy reduces angiogenesis and fibrosis in primate and murine macular degeneration.

Authors:  Ling Luo; Xiaohui Zhang; Yoshio Hirano; Puneet Tyagi; Péter Barabás; Hironori Uehara; Tadashi R Miya; Nirbhai Singh; Bonnie Archer; Yureeda Qazi; Kyle Jackman; Subrata K Das; Thomas Olsen; Srinivas R Chennamaneni; Brian C Stagg; Faisal Ahmed; Lyska Emerson; Kristen Zygmunt; Ross Whitaker; Christina Mamalis; Wei Huang; Guangping Gao; Sangly P Srinivas; David Krizaj; Judit Baffi; Jayakrishna Ambati; Uday B Kompella; Balamurali K Ambati
Journal:  ACS Nano       Date:  2013-03-20       Impact factor: 15.881

8.  Impact of scanning density on measurements from spectral domain optical coherence tomography.

Authors:  Srinivas R Sadda; Pearse A Keane; Yanling Ouyang; Jared F Updike; Alexander C Walsh
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-09-24       Impact factor: 4.799

9.  Assessment of differential pharmacodynamic effects using optical coherence tomography in neovascular age-related macular degeneration.

Authors:  Pearse A Keane; Florian M Heussen; Yanling Ouyang; Nils Mokwa; Alexander C Walsh; Adnan Tufail; Srinivas R Sadda; Praveen J Patel
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-09       Impact factor: 4.799

10.  Retinal pigment epithelium segmentation by polarization sensitive optical coherence tomography.

Authors:  Erich Götzinger; Michael Pircher; Wolfgang Geitzenauer; Christian Ahlers; Bernhard Baumann; Stephan Michels; Ursula Schmidt-Erfurth; Christoph K Hitzenberger
Journal:  Opt Express       Date:  2008-10-13       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.